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ABSTRACT: Hairy cell leukemia (HCL) is a rare disease 
of unknown origin and indolent course, which is detected 
in a complete blood count associated by pancytopenia and 
lymphocytes with cytoplasmic projections. This study presents 
a case report of a 31-year-old male patient, with pallor and no 
splenomegaly, who was admitted to the Municipal Hospital of 
Rondon do Pará, Amazônia, on December 31, 2018 to perform 
laboratory tests due to the worsening of his general condition. The 
complete blood count revealed: anemia (hemoglobin level of 7.5 
g/dL and hematocrit level of 20%), thrombocytopenia (28,200/
mm3) and hyperleukocytosis (179,000/mm3) while 88% of 
lymphocytes presented thin and elongated cytoplasmic projections 
suggestive of hairy cells. On January 7, 2019, the patient’s 
condition worsened, resulting in death before the diagnostic 
confirmation of the immunophenotyping test, which revealed a 
clonal population of 68.3% of hairy cells that expressed antigens 
CD19, CD20, CD79b, CD23, IgM, CD200, CD38, FMC-7, CD25 
and CD103. It was not possible to determine which factors were 
decisive to this situation.
Keywords: Hairy cell leukemia; Fatal outcome; Leukocytosis; 
Flow cytometry.
RESUMO: A Leucemia de Células Pilosas (LCP) é uma doença 
rara, de origem desconhecida, de curso indolente, e que se 
apresenta no hemograma associada a pancitopenia e linfócitos 
com projeções citoplasmáticas. No presente estudo apresentamos 
o relato de caso de um paciente de 31 anos, masculino, hipocorado, 
sem esplenomegalia, admitido no Hospital Municipal de Rondon 
do Pará, Amazônia, no dia 31.12.2018 para a realização de exames 
laboratoriais em função de rebaixamento do estado geral. O 
hemograma revelou: anemia (7.5g/dL de hemoglobina e 20% de 
hematócrito), plaquetopenia (28.200/mm3) e hiperleucocitose 
(179.000/mm3) as custas de 88% de linfócitos com projeções 
citoplasmáticas finas e alongadas sugestivas de células pilosas. No 
dia 07.01.2019 houve piora do quadro do paciente com evolução 
a óbito antes mesmo da confirmação diagnóstica pelo exame de 
imunofenotipagem que revelou tratava-se de população clonal de 
68,3% de células pilosas com expressão dos antígenos: CD19, 
CD20, CD79b, CD23, IgM, CD200, CD38, FMC-7, CD25 e 
CD103. Não tendo sido possível a determinação de quais fatores 
foram determinantes para esse quadro.
Palavras-chave: Leucemia de células pilosas; Tricoleucemia; 
Evolução fatal; leucocitose; Citometria de fluxo.
190
Nascimento AL, Brito Junior LC. Unusual case report of acute evolution hairy cell leukemia in a young adult 
INTRODUCTION
Chronic lymphoproliferative disorders (CLDs) represent the most frequent group of blood 
cancers in the world among individuals 50 years old and 
older, with very different clinical presentations, evolutions 
and prognoses. Its initial diagnosis is suggested by the 
presence of persistent lymphocytosis, i.e., more than 
5,000 lymphocytes/mm3, in three consecutive complete 
blood counts (CBCs)1,2. The diagnosis must then be 
confirmed using complementary tests such as imaging 
tests; myelograms; bone marrow, skin, spleen or lymph 
node biopsies; analysis of neoplastic cells in body cavity or 
cerebrospinal liquids; serum tests; immunophenotyping or 
immunohistochemistry tests; and cytogenetic or molecular 
exams1,3.
Among the various types of B-cell CLDs, hairy cell 
leukemia (HCL) stands out because of the morphological 
presentation of the lymphocytes. They contain round or 
oval nuclei, abundant cytoplasm with long and thin hair-
like projections (“hairy cells”) visible in the CBC, in bone 
marrow tests, and in the analysis of splenic red pulp1,3,4. 
Hairy cell leukemia is a rare disease of unknown 
origin with an incidence rate of 2% to 4% of all cases 
of lymphoid leukemias, although it has been associated 
by various authors with exposure to radiations, benzene, 
herbicides, and pesticides1,4,5,6. It affects mainly men (ratio 
of 5:1); white individuals (ratio of 3:1) in relation to those of 
other races, and the median age of patients is 55 years7,8,9,10. 
Clinically, HCL evolves slowly and is associated 
with splenomegaly, susceptibility to bacterial infections, in 
addition to anemia and hemorrhages. In advanced stages, 
it can also manifest in association with adenomegaly, 
hepatomegaly, and significant skin manifestations  3,7,8,9,10,11. 
Initial laboratory diagnosis of HCL requires 
the presence of pancytopenia followed by relative 
lymphocytosis, with the presence of “hairy cells”, and 
monocytopenia in the CBC1,3,4,7,8,11,12. However, the 
definite diagnosis of the disease depends on biopsies, 
which will reveal the presence of bone marrow fibrosis, 
immunohistochemistry tests; and flow cytometry 
immunophenotyping tests using blood marrow or peripheral 
blood cells, which will express mature B-lymphocyte 
antigens CD19, CD20, CD22, CD79b, and surface 
immunoglobulins (IgM), in variable co-expression with 
antigens FMC-7, CD25, CD11c, and CD103. The same 
cells will also be negative for CD5, CD10, and CD231,3,4,8,12.
Thus, the objective of this study was to report a case 
of acute evolution of hairy cell leukemia in association 
with hyperleukocytosis and a fatal outcome in a young 
adult patient. 
CASE DESCRIPTION
A 31-year-old male patient was admitted to the 
Rondon do Pará Municipal Hospital on December 31, 2018 
with a fever, chest pain, asthenia and general malaise. In 
the general clinical evaluation, he was pale but presented 
normal blood pressure (120 x 80 mmHg) and normal 
physiological functions, with no enlarged organs, vesicular 
murmurs or abnormal auscultation findings. Because of 
the clinical complaint at admission, he was hospitalized 
to be monitored and receive complementary tests from the 
Regional Hemocenter of Marabá, state of Pará. 
On January 4, 2019, the patient was referred to the 
Regional Hemocenter of Marabá for specialized care and 
to test for levels of serum iron (263µg/dL) and ferritin 
(2,262ng/mL) which were high; to perform serology for 
hepatitis B and C, human immunodeficiency virus (HIV 
I/II), human t-cell lymphotropic virus (HTLV), Chagas 
disease, and syphilis, all of which were non-reactive; and 
a CBC that revealed anemia (RBC - 2.01 million/mm3, 
hemoglobin - 7.5g/dL, hematocrit - 20% and red cell 
distribution width (RDW) - 15.8%), thrombocytopenia 
(28,200/mm3), and hyperleukocytosis (179,000/mm3). The 
differential white blood cell (WBC) count performed by 
the equipment presented confusing results and alerted to 
the presence of immature granulocytes and/or blasts. Thus, 
the sample was sent to the Coordinating Hemocenter of 
Belém to carry out a morphological confirmation of the 
WBC differential count. 
Using a common light microscope at the Coordinating 
Hemocenter of Belém, the peripheral blood smear analysis 
revealed the presence of 12,530 neutrophils/mm3 (7%), 
8,950 monocytes/mm3 (5%) and 157,520 lymphocytes/
mm3 (88%) with specific cytomorphological abnormalities, 
such as long and thin cytoplasmatic projections, suggestive 
of hairy cells (Figure 1). Immediately after this analysis, 
the peripheral blood was sent for flow cytometry 
immunophenotyping in another specialized center in 
Belém, Pará, to confirm the diagnostic hypothesis. 
On January 5, 2019, the patient’s overall condition 
began to worsen, with epigastric pain that irradiated to 
the back, asthenia, and increased pallor. On January 7, 
2019, new lab tests were conducted: glucose (60mg/dL); 
creatinine (1.10mg/dL); blood urea nitrogen (38mg/dL) 
and a CBC that revealed: bicytopenia of the red blood cells 
(erythrocytes – 1.66 million/mm3; hemoglobin - 5.6g/dL; 
hematocrits - 16.30%) and of the platelets (9,000 platelets/
mm3); in addition to the maintenance of hyperleukocytosis 
(131,500 leukocytes/mm3) with 97% of WBC, whose 
morphology suggested HCL.
Stil l  on January 6,  2019, the patient’s 
condition deteriorated rapidly, resulting in death. The 
immunophenotyping test revealed a clonal population 
of 68.3% of cells that expressed mature B-lymphocyte 
antigens CD19, CD20, CD79b, CD23, IgM, and CD200, 
and a kappa/lambda ratio = 0.9; in addition to expressing 
cellular activation antigens CD38 and FMC-7; and antigens 
CD25 and CD103, which characterize the disease. Finally, 
the test was negative for both CD5 and CD10.
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Figure 1: Lymphocytes with cytoplasmatic hair-like projections 
(“hairy cells”).
DISCUSSION
According to the clinical laboratory and 
immunophenotypical criteria, the case presented in 
this article may refer to classic HCL that could have 
presented a good prognosis because of the absence of 
splenomegaly and the patient’s young age. However, 
anemia, thrombocytopenia, high WBC count, the 
impossibility of investigating the BRAFV600E mutation 
that could better characterize the classic form of the disease, 
and the acute evolution of his condition possibly impaired 
the patient’s prognosis, as has been well described in the 
literature3,7,8,11,13,14.
Salam and Abdel-Wahab8 have cited in their 
studies that in very rare cases, patients with classic HCL 
may present CBCs with WBC counts greater than 10,000 
leukocytes/mm3. Rudolf-Oliveira et al.14, in turn, reported 
that leukocytosis is a more common finding in patients with 
HCL-variant. Several authors define that the classification 
of HCL into classic or variant can be based on criteria 
such as the patient’s WBC count; therefore, according to 
this criterion, it is possible that the patient in question had 
classic HCL, however, with some genetic mutation that 
resulted in an increase in WBC count and consequently 
led to a fatal outcome1,3,8. 
Another factor that may have been crucial to the 
disease’s acute evolution in this patient was the possible 
delay in seeking medical care, because the patient already 
presented significant anemia and thrombocytopenia when 
he was admitted. In their studies, Salam and Abdel-Wahab8 
suggest that anemia and thrombocytopenia are two of the 
main factors that limit the success of treatment for people 
with HCL. Secioso, Cardoso and Frazão11 published a case 
report in which they assessed that the slow course of the 
disease and delays in diagnosing patients with HLC can 
produce serious infectious complications and culminate in 
the death of patients even before diagnosis. 
Haouach et al.15 presented a case report of a patient 
with HCL and tuberculosis and indicated that it is already 
common sense that patients with HCL have a special 
predisposition to mycobacterial infections in about 8% 
of cases. However, even though the patient in their study 
presented fever, chest pain, asthenia and general malaise, 
which are general symptoms in the course of HLC1,8,11 and 
also tuberculosis, the hypothesis of tuberculosis or any 
other associated infection was not investigated during the 
patient’s care because of the acute evolution of the disease.
The geographic origin of the patient in the present 
case study, Rondon do Pará, a predominantly rural town, 
reinforces the hypothesis that there may be an association 
between HCL and the use of pesticides in the Brazilian 
Amazon region, as has been recorded by our research group 
in other studies2,4. 
Barbosa et al.5, for example, conducted an 
epidemiological study about cases of leukemia and 
lymphomas in the state of Pará between 2005 and 2011, and 
observed that the main occupation of 19.2% of patients was 
agriculture, and that the use of pesticides was a common 
practice in their daily routine.  
In his studies about the use of pesticides in the 
Brazilian Amazon region, Waichman6 showed that several 
factors contribute to the indiscriminate and incorrect use 
of these products in this part of the country. These include 
low education levels (illiteracy) of farmers who manipulate 
and apply the products; lack of preparation relative to the 
risks involved when using and disposing empty pesticide 
packages; lack of personal protection equipment; and free 
and indiscriminate sale of pesticides in the region. These 
factors contribute to an increased risk of contamination 
not only of farmers, but also of their family members and 
the environment. 
CONCLUSION
Classic HCL is a chronic lymphoproliferative 
disorder that progresses slowly; however, as shown in 
this case report, there are patients with associated cases of 
hyperleukocytosis and fatal outcomes. It is essential that 
more studies be conducted to clarify which factors are 
associated with the emergence of the disease and these 
aggressive forms of HCL.
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